Bibliography

Found 48 results
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Byrd D, Rivera-Mindt M, Ryan EL, Morgello S. HIV-Related Cognitive Disorders in U.S. Ethnic Minorities: Influence of confounds and classification systems. In: 34th Annual Meeting of the International Neuropsychological Society. 34th Annual Meeting of the International Neuropsychological Society. ; 2006.
Byrd DA, Fellows RP, Morgello S, Franklin D, Heaton RK, Deutsch R, J Atkinson H, Clifford DB, Collier AC, Marra CM, et al. Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr. 2011 ;58(2):154-62.
Byrd D, Murray J, Safdieh G, Morgello S. Impact of opiate addiction on neuroinflammation in HIV. J Neurovirol [Internet]. 2012 . Available from: http://www.ncbi.nlm.nih.gov/pubmed/22797933
Byrd D, Robinson-Papp JS, Rivera-Mindt M, Mintz L, Elliott K, Lighty Q, Morgello S. Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study. Journal of the International Neuropsychological Society (JINS) [Internet]. 2013 ;19(4):463-473. Available from: http://www.ncbi.nlm.nih.gov/pubmed/?term=23446056
Byne W, Lasco MS, Kemether E, Shinwari A, Edgar MA, Morgello S, Jones LB, Tobet S. The interstitial nuclei of the human anterior hypothalamus: an investigation of sexual variation in volume and cell size, number and density. Brain Research [Internet]. 2000 ;856(1-2):254-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10677635
Byne W, Tobet S, Mattiace LA, Lasco MS, Kemether E, Edgar MA, Morgello S, Buchsbaum MS, Jones LB. The interstitial nuclei of the human anterior hypothalamus: an investigation of variation with sex, sexual orientation, and HIV status. Hormones and Behavior [Internet]. 2001 ;40(2):86-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11534967
Buzhdygan T, Lisinicchia J, Patel V, Johnson K, Neugebauer V, Paessler S, Jennings K, Gelman B. Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection. J Neuroimmune Pharmacol. 2016 ;11(2):279-93.
Buyukturkoglu K, Fleyser L, Byrd D, Morgello S, Inglese M. Diffusion Kurtosis Imaging Shows Similar Cerebral Axonal Damage in Patients with HIV Infection and Multiple Sclerosis. J Neuroimaging. 2018 ;28(3):320-327.
Burdo TH, Ellis RJ, Fox HS. Osteopontin is increased in HIV-associated dementia. The Journal of Infectious Diseases [Internet]. 2008 ;198:715-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18616394
Bryant AK, Ellis RJ, Umlauf A, Gouaux B, Soontornniyomkij V, Letendre SL, Achim CL, Masliah E, Grant I, Moore DJ. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS. 2015 ;29(3):323-30.
Bryant AK, Moore DJ, Burdo TH, Lakritz JR, Gouaux B, Soontornniyomkij V, Achim CL, Masliah E, Grant I, Levine AJ, et al. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 ;31(7):973-979.
Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. Journal of the American Society of Nephrology: JASN [Internet]. 2000 ;11(11):2079-87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11053484
Brown A, Islam T, Adams R, Nerle S, Kamara M, Eger C, Marder K, Cohen BA, Schifitto G, McArthur JC, et al. Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. Journal of NeuroVirology [Internet]. 2011 ;17(4):382-392. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21556958
Brown A. Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection. [Internet]. 2015 ;4(1):7. Available from: https://doi.org/10.1186/s40169-015-0049-2
Brown A, Sacktor N, Marder K, Cohen BA, Schifitto G, Skolasky RL, Creighton J, Guo L, McArthur JC. CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorder. Journal of Current Biomarker Findings [Internet]. 2012 ;2012(2):1-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23814703
Brown A, Skolasky RL, Marder K, Cohen BA, Schifito G, Creighton J, Guo L, McArthur JC. CCL3L1 gene copy number in the Northeast AIDS Dementia (NEAD) Cohort and the National NeuroAIDS Tissue Consortium (NNTC). In: Conference on Retroviruses. Conference on Retroviruses. ; 2009.
Brouillette M-J, Yuen T, Fellows LK, Cysique LA, Heaton RK, Mayo NE. Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis. PLoS One. 2016 ;11(5):e0155766.
Branton WG, Fernandes JP, Mohammadzadeh N, Doan MAL, Laman JD, Gelman BB, Fagrouch Z, Kondova I, Mooij P, Koopman G, et al. Microbial molecule ingress promotes neuroinflammation and brain CCR5 expression in persons with HIV-associated neurocognitive disorders. Brain Behav Immun. 2023 ;107:110-123.
P Bozzelli L, Yin T, Avdoshina V, Mocchetti I, Conant KE, Maguire-Zeiss KA. HIV-1 Tat promotes astrocytic release of CCL2 through MMP/PAR-1 signaling. Glia. 2019 ;67(9):1719-1729.
Borjabad A, Morgello S, Chao W, Kim SY, Brooks AI, Murray J, Potash MJ, Volsky DJ. Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders. PLoS Pathogens [Internet]. 2011 ;7(9). Available from: http://www.ncbi.nlm.nih.gov/pubmed/21909266
Borjabad A, Chao W, Kin SY, Brooks AI, Murray J, Morgello S, Volsky DJ. Highly active antiretroviral therapy ameliorates gene expression changes in the brain of patients with HIV-associated dementia. In: 5th Symposium on the fuctional genomics of critical illness and injury. 5th Symposium on the fuctional genomics of critical illness and injury. Bethesda, MD; 2007.
Bonwetsch R, Croul S, Richardson MW, Lorenzana C, Del-Valle L, Sverstiuk AE, Amini S, Morgello S, Khalili K, Rappaport J. Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. Journal of NeuroVirology [Internet]. 1999 ;5(6):685-694. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10602409
Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, et al. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012 ;26(6):894-908.
Blackstone K, Moore DJ, Heaton RK, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, et al. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012 ;18(1):79-88.
Biswas B, Spitznagel E, Collier AC, Gelman BB, McArthur JC, Morgello S, McCutchan JA, Clifford DB. Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort. J HIV AIDS Soc Serv. 2014 ;13(1):8-25.

Pages